Regeneron Pharmaceuticals Inc. buy Barclays PLC
Start price
23.01.24
/
50%
€873.50
Target price
23.01.25
€938.09
Performance (%)
-24.40%
End price
24.01.25
€660.40
Summary
This prediction ended on 24.01.25 with a price of €660.40. The prediction for Regeneron Pharmaceuticals Inc. disappointed with a performance of -24.40%. Barclays_PLC has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Barclays_PLC has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -0.340% | -0.340% | 22.275% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Barclays_PLC for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Barclays PLC from $935.00 to $1,020.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€651.80
06.03.26
06.03.26
€794.33
06.03.27
06.03.27
-7.62%
18:13
18:13
Stopped prediction by Barclays_PLC for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€604.40
30.04.26
30.04.26
€785.87
30.04.27
30.04.27
-0.37%
18:13
18:13
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€775.00
01.11.24
01.11.24
€981.82
01.11.25
01.11.25
-26.71%
02.11.25
02.11.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€871.00
23.10.24
23.10.24
€1,001.5
23.10.25
23.10.25
-43.20%
24.10.25
24.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€990.00
02.08.24
02.08.24
€1,116.5
02.08.25
02.08.25
-51.29%
03.08.25
03.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€989.60
11.07.24
11.07.24
€1,101.8
11.07.25
11.07.25
-50.80%
12.07.25
12.07.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€705.50
07.08.23
07.08.23
€817.83
07.08.24
07.08.24
37.94%
08.08.24
08.08.24